NeXtGen™ Biologics

nextgenbiologics.com

nextgenbiologics.com • HQ: Alachua, United States • Venture - Series Unknown 2025 • Founded 2014 • Startup • New

HQ: Alachua, United States • Venture - Series Unknown 2025 • Founded 2014 • Startup • New

Actively hiring

Cell & Gene Therapy

Health Care

Biologics & Biosimilars

Overview

Salaries

Products

People

Growth

Offices

Financials

Funding and backers

Total raised

$230k

2 rounds on record

Latest round

$130k

Venture round · Jul 2025 · 14 mo ago

The money's age

Due for its next round

14 months since the last round · not hiring

Momentum

0/100

no fresh signals

The story so fareach stage dated by its source: the company's releases, the press, registers, filings

Jul 30, 2025 Raised a round Venture round $130k · SEC Form D Jul 22, 2019 Raised a round Venture round $100k · SEC Form D 2014 Founded

Funding rounds

Round	Date	Amount	Investors	Source
Venture round	Jul 2025	$130k	—	SEC Form D
Venture round	Jul 2019	$100k	—	SEC Form D

Registers and programsofficial lists and records that name the company

Legal entity

NeXtGen Biologics, INC

SEC Form D

Founders and leadersfrom filings, registers and the company's site

Jonelle ToothmanExecutive Officer, DirectorSEC Form D

Investors in similar startupsfunds that back the companies most like this one

RA Capital Management

backs Ausperbio

Meta Planet

backs Ancilia Bio

Qiming Venture Partners

backs Ausperbio

Horizons Ventures

backs Theradaptive

LAV

backs Skyline Therapeutics

AIX Ventures

backs Stately Bio

Similar startupsby what they do, their industry and backers

TheradaptiveVenture round $36.2M · 2 mo ago

Theradaptive aims to redefine the regenerative medicine field by delivering therapeutics to any location in the body with precision.

Stately BioSeed $12M · 17 mo ago • 1-10 employees

Stately Bio is developing the next generation of life-saving regenerative medicines with the world.

Ancilia Bio201-500 employees

CRISPR-mediated viral immunity. Designed by nature, harnessed by Ancilia.

AusperbioSeries C $120M · 1 mo ago

AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming HBV treatment for cure and advancing…

D&P Bioinnovations

Discover Regenerative Medicine with D&P Bioinnovations. Transformative solutions for healing damaged tissues. Call us.

Sylvatica Biotech Inc51-200 employees

About Careers Contact Policies Scroll At Sylvatica, we're reimagining human health. We strive to transform organ transplantation, drug…

Overview

0 At Nextgen Biologics, we are dedicated to advancing the future of regenerative medicine through science inspired by nature. Our work centers around the unique regenerative abilities of the axolotl, a species known for its extraordinary capacity to heal and restore tissue.